Balsalazide Disodium Capsule
Product Images NDC 60505-2575

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Balsalazide Disodium (NDC 60505-2575). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

750mg-280caps (750mg 280caps)

Label for Balsalazide Disodium Capsules, USP 750 mg, showing a count of 280 capsules. The label includes storage instructions, dispensing information, and manufacturer details for Apotex Corp. The product is Rx only and intended for oral use.*

FDA Label Image

Figure-1 (Figure 1)

A bar graph comparing the percentage of patients improved in stool blood, stool frequency, and sigmoidoscopy between two Balsalazide dosages: 2.25 g (0.8 mesalamine equivalents) and 6.75 g (2.4 mesalamine equivalents). The higher dosage shows greater improvement across all three categories, with statistical significance indicated by p-values.*

FDA Label Image

Structural-formula (Structural Formula)

Chemical structure of Balsalazide Disodium, showing the arrangement of aromatic rings, azo bond, carboxylate, amide, and sodium ions, along with two water molecules as part of the structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.